Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9552)
All Articles published online
|
Publishing Process of This Article
|
May 28, 2013 (publication date) through Dec 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lv WS, Sun RX, Gao YY, Wen JP, Pan RF, Li L, Wang J, Xian YX, Cao CX, Zheng M. Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes. World J Gastroenterol 2013; 19(20): 3134-3142 [PMID: 23716995 DOI: 10.3748/wjg.v19.i20.3134] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i20/3134.htm |
| Number | Citing Articles |
| 1 |
Jinya Huang, Rumei Li, Naijia Liu, Na Yi, Hangping Zheng, Qi Zhang, Lianying Zhou, Linuo Zhou, Renming Hu, Bin Lu. Liver fibrosis is independently associated with diabetic peripheral neuropathy in type 2 diabetes mellitus. Journal of Diabetes Investigation 2021; 12(11): 2019 doi: 10.1111/jdi.13562
|
| 2 |
Qi Zhang, Jing Liu, Jia Liu, Wenhui Huang, Limin Tian, Jinxing Quan, Yunfang Wang, Ruilan Niu. oxLDL induces injury and defenestration of human liver sinusoidal endothelial cells via LOX1. Journal of Molecular Endocrinology 2014; 53(2): 281 doi: 10.1530/JME-14-0049
|
| 3 |
Evelyn Nunes Goulart da Silva Pereira, Raquel Rangel Silvares, Karine Lino Rodrigues, Edgar Eduardo Ilaquita Flores, Anissa Daliry. Pyridoxamine and Caloric Restriction Improve Metabolic and Microcirculatory Abnormalities in Rats with Non-Alcoholic Fatty Liver Disease. Journal of Vascular Research 2021; 58(2): 121 doi: 10.1159/000512832
|
| 4 |
Guoyu Jia, Fusheng Di, Qipeng Wang, Jinshuang Shao, Lei Gao, Lu Wang, Qiang Li, Nali Li, Hervé Guillou. Non-Alcoholic Fatty Liver Disease Is a Risk Factor for the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus. PLOS ONE 2015; 10(11): e0142808 doi: 10.1371/journal.pone.0142808
|
| 5 |
Dan Ziegler, Alexander Strom, Yuliya Kupriyanova, Alessandra Bierwagen, Gidon J Bönhof, Kálmán Bódis, Karsten Müssig, Julia Szendroedi, Pavel Bobrov, Daniel F Markgraf, Jong-Hee Hwang, Michael Roden. Association of Lower Cardiovagal Tone and Baroreflex Sensitivity With Higher Liver Fat Content Early in Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism 2018; 103(3): 1130 doi: 10.1210/jc.2017-02294
|
| 6 |
Nihar Ranjan Sahoo, Motij Kumar Dalai, Deepak Kumar Dash, Ganeswar Sethy. Prevalence, Metabolic Consequences of Non Alcoholic Fatty Liver Disease (NAFLD) and its Association with Microvascular Complications and Ventricular Dysfunction in Patients with Type 2 Diabetes Mellitus. Medical Journal of Dr. D.Y. Patil Vidyapeeth 2024; 17(1): 149 doi: 10.4103/mjdrdypu.mjdrdypu_490_22
|
| 7 |
Wenjie Dai, Ling Ye, Aizhong Liu, Shi Wu Wen, Jing Deng, Xin Wu, Zhiwei Lai. Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. Medicine 2017; 96(39): e8179 doi: 10.1097/MD.0000000000008179
|
| 8 |
Jiang Deng, Zhiyi Han, Hailing Tang, Cong Yao, Xiaoling Li, Jingyuan Xu, Mimi Zhou, Xin Xing, Fangxiong Wu, Jianning Li, Xiaolan Lu, Haitao Shi. Elevated fasting glucose level increases the risk of fatty liver disease: a 10-year study of 31,154 individuals. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02615-0
|
| 9 |
Zahra Heidari, Zahra Sharafi. Association of Non-Alcoholic Fatty Liver Dis-ease and Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus: a Cross-Sectional Study. Iranian South Medical Journal 2022; 25(1): 30 doi: 10.52547/ismj.25.1.30
|
| 10 |
F. W. D. Tai, W.‐K. Syn, W. Alazawi. Practical approach to non‐alcoholic fatty liver disease in patients with diabetes. Diabetic Medicine 2015; 32(9): 1121 doi: 10.1111/dme.12725
|
| 11 |
Mark A. Yorek. The Potential Role of Fatty Acids in Treating Diabetic Neuropathy. Current Diabetes Reports 2018; 18(10) doi: 10.1007/s11892-018-1046-9
|
| 12 |
Zhi-Hui Zhang, Jiang-Feng Ke, Jun-Xi Lu, Yun Liu, Ai-Ping Wang, Lian-Xi Li. Serum Retinol-Binding Protein Levels Are Associated with Nonalcoholic Fatty Liver Disease in Chinese Patients with Type 2 Diabetes Mellitus: A Real-World Study. Diabetes & Metabolism Journal 2022; 46(1): 129 doi: 10.4093/dmj.2020.0222
|
| 13 |
Alessandro Mantovani, Riccardo Rigolon, Lucia Mingolla, Isabella Pichiri, Valentina Cavalieri, Laura Salvotelli, Vincenzo Stoico, Giacomo Zoppini, Enzo Bonora, Giovanni Targher. Nonalcoholic fatty liver disease is associated with an increased prevalence of distal symmetric polyneuropathy in adult patients with type 1 diabetes. Journal of Diabetes and its Complications 2017; 31(6): 1021 doi: 10.1016/j.jdiacomp.2017.01.024
|
| 14 |
Elina En Li Cho, Chong Zhe Ang, Jingxuan Quek, Clarissa Elysia Fu, Lincoln Kai En Lim, Zane En Qi Heng, Darren Jun Hao Tan, Wen Hui Lim, Jie Ning Yong, Rebecca Zeng, Douglas Chee, Benjamin Nah, Cosmas Rinaldi Adithya Lesmana, Aung Hlaing Bwa, Khin Maung Win, Claire Faulkner, Majd B Aboona, Mei Chin Lim, Nicholas Syn, Anand V. Kulkarni, Hiroyuki Suzuki, Hirokazu Takahashi, Nobuharu Tamaki, Karn Wijarnpreecha, Daniel Q. Huang, Mark Muthiah, Cheng Han Ng, Rohit Loomba. Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis. Gut 2023; 72(11): 2138 doi: 10.1136/gutjnl-2023-330110
|
| 15 |
Hidemi Goto, Kosuke Tachi, Atsuko Watarai, Taro Mizutani, Go Kajikawa, Michiyo Yoshizaki, Komei Matsushita, Yuki Ito, Yuko Shimizu, Kazuhiko Hayashi, Kentaro Yoshioka, Ryosuke Yamane. Prevalence of nonalcoholic fatty liver disease and its association with age in patients with type 2 diabetes mellitus. World Journal of Hepatology 2022; 14(6): 1226-1234 doi: 10.4254/wjh.v14.i6.1226
|
| 16 |
Yongxia Lu, Wei Wang, Jingyu Liu, Min Xie, Qiang Liu, Sufang Li. Vascular complications of diabetes: A narrative review. Medicine 2023; 102(40): e35285 doi: 10.1097/MD.0000000000035285
|
| 17 |
Ahmed O. Almobarak, Salma Barakat, Eltayeb A. Suliman, Wadie M. Elmadhoun, Nabeel A. Mohamed, Israa O. Abobaker, Sufian K. Noor, Sarra O. Bushara, Mohamed H. Ahmed. Prevalence of and predictive factors for nonalcoholic fatty liver disease in Sudanese individuals with type 2 diabetes: Is metabolic syndrome the culprit?. Arab Journal of Gastroenterology 2015; 16(2): 54 doi: 10.1016/j.ajg.2015.06.001
|
| 18 |
翠愿 郭. Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease: Correlation and Management. Advances in Clinical Medicine 2024; 14(08): 605 doi: 10.12677/acm.2024.1482257
|
| 19 |
Karn Wijarnpreecha, Charat Thongprayoon, Boonphiphop Boonpheng, Panadeekarn Panjawatanan, Konika Sharma, Patompong Ungprasert, Surakit Pungpapong, Wisit Cheungpasitporn. Nonalcoholic fatty liver disease and albuminuria: a systematic review and meta-analysis. European Journal of Gastroenterology & Hepatology 2018; 30(9): 986 doi: 10.1097/MEG.0000000000001169
|
| 20 |
Paola Portillo-Sanchez, Fernando Bril, Maryann Maximos, Romina Lomonaco, Diane Biernacki, Beverly Orsak, Sreevidya Subbarayan, Amy Webb, Joan Hecht, Kenneth Cusi. High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels. The Journal of Clinical Endocrinology & Metabolism 2015; 100(6): 2231 doi: 10.1210/jc.2015-1966
|
| 21 |
Michel P. Hermans, Evariste Bouenizabila, K. Daniel Amoussou-Guenou, C. Jules Gninkoun, Sylvie A. Ahn, Michel F. Rousseau. Fatty liver and atherogenic dyslipidemia have opposite effects on diabetic micro- and macrovascular disease. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2022; 16(10): 102613 doi: 10.1016/j.dsx.2022.102613
|
| 22 |
Cristina M. Muzica, Catalin Sfarti, Anca Trifan, Sebastian Zenovia, Tudor Cuciureanu, Robert Nastasa, Laura Huiban, Camelia Cojocariu, Ana-Maria Singeap, Irina Girleanu, Stefan Chiriac, Carol Stanciu, Branka Filipović. Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: A Bidirectional Relationship. Canadian Journal of Gastroenterology and Hepatology 2020; 2020: 1 doi: 10.1155/2020/6638306
|
| 23 |
Anca Trifan, Ermina Stratina, Robert Nastasa, Adrian Rotaru, Remus Stafie, Sebastian Zenovia, Laura Huiban, Catalin Sfarti, Camelia Cojocariu, Tudor Cuciureanu, Cristina Muzica, Stefan Chiriac, Irina Girleanu, Ana-Maria Singeap, Carol Stanciu. Simultaneously Screening for Liver Steatosis and Fibrosis in Romanian Type 2 Diabetes Mellitus Patients Using Vibration-Controlled Transient Elastography with Controlled Attenuation Parameter. Diagnostics 2022; 12(7): 1753 doi: 10.3390/diagnostics12071753
|
| 24 |
Qianqian Yan, Zihao Zhao, Dongwei Liu, Jia Li, Shaokang Pan, Jiayu Duan, Jiancheng Dong, Zhangsuo Liu. Integrated analysis of potential gene crosstalk between non-alcoholic fatty liver disease and diabetic nephropathy. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1032814
|
| 25 |
Keith G. McCormick, Eleonora Scorletti, Lokpal Bhatia, Philip C. Calder, Michael J. Griffin, Geraldine F. Clough, Christopher D. Byrne. Impact of high dose n-3 polyunsaturated fatty acid treatment on measures of microvascular function and vibration perception in non-alcoholic fatty liver disease: results from the randomised WELCOME trial. Diabetologia 2015; 58(8): 1916 doi: 10.1007/s00125-015-3628-2
|
| 26 |
Ming-Wai Yeung, Grace Lai-Hung Wong, Kai Chow Choi, Andrea On-Yan Luk, Raymond Kwok, Sally She-Ting Shu, Anthony Wing-Hung Chan, Eric Siu Him Lau, Ronald Ching Wan Ma, Henry Lik-Yuen Chan, Juliana Chung-Ngor Chan, Vincent Wai-Sun Wong, Alice Pik-Shan Kong. Advanced liver fibrosis but not steatosis is independently associated with albuminuria in Chinese patients with type 2 diabetes. Journal of Hepatology 2018; 68(1): 147 doi: 10.1016/j.jhep.2017.09.020
|
| 27 |
Pijun Yan, Yuru Wu, Xiaofang Dan, Xian Wu, Qian Tang, Xiping Chen, Yong Xu, Jianhua Zhu, Ying Miao, Qin Wan. Aspartate aminotransferase/alanine aminotransferase ratio was associated with type 2 diabetic peripheral neuropathy in a Chinese population: A cross-sectional study. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1064125
|
| 28 |
Dipali K Chatur, Saroj K Pati, Jayshri R Ghate, Rachita Nanda, Meenakshi Sinha, Kalpana Kodapi. Nonalcoholic Fatty Liver Disease in Shift Workers and Its Effect on Peripheral Nerve Conduction: A Cross-Sectional Study. Cureus 2024; doi: 10.7759/cureus.60632
|
| 29 |
Qinpei Ding, Yubo Zhou, Shu Zhang, Min Liang. Association between hemoglobin levels and non-alcoholic fatty liver disease in patients with young-onset type 2 diabetes mellitus. Endocrine Journal 2020; 67(11): 1139 doi: 10.1507/endocrj.EJ20-0071
|
| 30 |
Kathryn H. Williams, Kharis Burns, Maria Constantino, Nicholas A. Shackel, Emilia Prakoso, Jencia Wong, Ted Wu, Jacob George, Geoffrey W. McCaughan, Stephen M. Twigg. An association of large-fibre peripheral nerve dysfunction with non-invasive measures of liver fibrosis secondary to non-alcoholic fatty liver disease in diabetes. Journal of Diabetes and its Complications 2015; 29(8): 1240 doi: 10.1016/j.jdiacomp.2015.06.015
|
| 31 |
Kyuho Kim, Tae Jung Oh, Hyen Chung Cho, Yun Kyung Lee, Chang Ho Ahn, Bo Kyung Koo, Jae Hoon Moon, Sung Hee Choi, Hak Chul Jang. Liver fibrosis indices are related to diabetic peripheral neuropathy in individuals with type 2 diabetes. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-03870-z
|
| 32 |
Wan-Ching Chang, Huijuan Jia, Wanping Aw, Kenji Saito, Sumio Hasegawa, Hisanori Kato. Beneficial effects of soluble dietary Jerusalem artichoke (Helianthus tuberosus) in the prevention of the onset of type 2 diabetes and non-alcoholic fatty liver disease in high-fructose diet-fed rats. British Journal of Nutrition 2014; 112(5): 709 doi: 10.1017/S0007114514001421
|
| 33 |
Si-Wen Dang, Lei Gao, Yu-Jun Li, Ruo Zhang, Jing Xu. Metabolic characteristics of non-obese and obese metabolic dysfunction-associated fatty liver disease in type 2 diabetes mellitus and its association with diabetic peripheral neuropathy and diabetic retinopathy. Frontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1216412
|
| 34 |
Guo-heng Zhang, Tian-hao Yuan, Zhen-sheng Yue, Lin Wang, Guo-Rui Dou. The presence of diabetic retinopathy closely associated with the progression of non-alcoholic fatty liver disease: A meta-analysis of observational studies. Frontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.1019899
|
| 35 |
Niki Katsiki, Panagiotis Anagnostis, Kalliopi Kotsa, Dimitrios G. Goulis, Dimitri P. Mikhailidis. Obesity, Metabolic Syndrome and the Risk of Microvascular Complications in Patients with Diabetes mellitus. Current Pharmaceutical Design 2019; 25(18): 2051 doi: 10.2174/1381612825666190708192134
|
| 36 |
Ningyuan Liu, Ge Wang, Chao Liu, Jiayi Liu, Shengyuan Huang, Yong Zhou, Enhua Xiao. Non‐alcoholic fatty liver disease and complications in type 1 and type 2 diabetes: A Mendelian randomization study. Diabetes, Obesity and Metabolism 2023; 25(2): 365 doi: 10.1111/dom.14877
|
| 37 |
Myrsini Orfanidou, Charikleia Ntenti, Kleo Evripidou, Asimina Mataftsi, Antonis Goulas, Stergios A. Polyzos. Retinal Vascular Lesions in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. Journal of Personalized Medicine 2023; 13(7): 1148 doi: 10.3390/jpm13071148
|
| 38 |
Tian-Hao Yuan, Zhen-Sheng Yue, Guo-Heng Zhang, Lin Wang, Guo-Rui Dou. Beyond the Liver: Liver-Eye Communication in Clinical and Experimental Aspects. Frontiers in Molecular Biosciences 2021; 8 doi: 10.3389/fmolb.2021.823277
|
| 39 |
Qing Pang, Jing-Yao Zhang, Si-Dong Song, Kai Qu, Xin-Sen Xu, Su-Shun Liu, Chang Liu. Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index. World Journal of Gastroenterology 2015; 21(5): 1650-1662 doi: 10.3748/wjg.v21.i5.1650
|
| 40 |
Niloofar Deravi, Fatemeh Dehghani Firouzabadi, Fatemeh Moosaie, Hassan Asadigandomani, Melika Arab Bafrani, Niyoosha Yoosefi, Amirhossein Poopak, Mohammad Dehghani Firouzabadi, Mohadeseh Poudineh, Soghra Rabizadeh, Ibrahim Kamel, Manouchehr Nakhjavani, Alireza Esteghamati. Non-alcoholic fatty liver disease and incidence of microvascular complications of diabetes in patients with type 2 diabetes: a prospective cohort study. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1147458
|
| 41 |
H. Li, B. Hu, L. Wei, L. Zhou, L. Zhang, Y. Lin, B. Qin, Y. Dai, Z. Lu. Non‐alcoholic fatty liver disease is associated with stroke severity and progression of brainstem infarctions. European Journal of Neurology 2018; 25(3): 577 doi: 10.1111/ene.13556
|
| 42 |
Giovanni Targher, Amedeo Lonardo, Christopher D. Byrne. Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus. Nature Reviews Endocrinology 2018; 14(2): 99 doi: 10.1038/nrendo.2017.173
|
| 43 |
Abd Elkhalek Hamed, Medhat Elsahar, Nadia M. Elwan, Sarah El-Nakeep, Mervat Naguib, Hanan Hamed Soliman, Ashraf Ahmed Aboubakr, Amany AbdelMaqsod, Heba Sedrak, Samir N. Assaad, Reda Elwakil, Gamal Esmat, Samira Salh, Taymour Mostafa, Sherif Mogawer, Sameh Emil Sadek, Maha M. Saber, Hanan Ezelarab, Asem Ashraf Mahmoud, Souad Sultan, Mohamed El Kassas, Ehab Kamal, Naglaa M. ElSayed, Shorouk moussa. Managing diabetes and liver disease association. Arab Journal of Gastroenterology 2018; 19(4): 166 doi: 10.1016/j.ajg.2018.08.003
|
| 44 |
Yang Li, Qiu Zhang, Suyan Tian. Causal associations between liver enzymes and diabetic microvascular complications: A univariable and multivariable Mendelian randomization. PLOS ONE 2024; 19(1): e0296894 doi: 10.1371/journal.pone.0296894
|
| 45 |
Evangelos Cholongitas, Dimitrios Tsilingiris, Panagiota Diamantopoulou, Elpida Mastrogianni, Anastasios Tentolouris, Dimitrios Karagiannakis, Ioannis Moyssakis, George V. Papatheodoridis, Nikolaos Tentolouris. Association of cardiovascular factors in diabetic patients with non-alcoholic fatty liver disease. Hormones 2022; 21(1): 133 doi: 10.1007/s42000-021-00334-x
|
| 46 |
Sui-Weng Wong, Wah-Kheong Chan. Epidemiology of non-alcoholic fatty liver disease in Asia. Indian Journal of Gastroenterology 2020; 39(1): 1 doi: 10.1007/s12664-020-01018-x
|
| 47 |
Li‐hui Yan, Biao Mu, Yue Guan, Xinyu Liu, Nan Zhao, Da Pan, Shao‐zhen Wang. Assessment of the relationship between non‐alcoholic fatty liver disease and diabetic complications. Journal of Diabetes Investigation 2016; 7(6): 889 doi: 10.1111/jdi.12518
|
| 48 |
Aditi R. Saxena, Stephanie‐An Lyle, Kaivan Khavandi, Ruolun Qiu, Mark Whitlock, William P. Esler, Albert M. Kim. A phase 2a, randomized, double‐blind, placebo‐controlled, three‐arm, parallel‐group study to assess the efficacy, safety, tolerability and pharmacodynamics of PF‐06835919 in patients with non‐alcoholic fatty liver disease and type 2 diabetes. Diabetes, Obesity and Metabolism 2023; 25(4): 992 doi: 10.1111/dom.14946
|
| 49 |
Manoj Kumar, Ashwin Parchani, Ravi Kant, Arindam Das. Relationship Between Vitamin D Deficiency and Non-alcoholic Fatty Liver Disease: A Cross-Sectional Study From a Tertiary Care Center in Northern India. Cureus 2023; doi: 10.7759/cureus.34921
|
| 50 |
T.-T. Li, A.-P. Wang, J.-X. Lu, M.-Y. Chen, C.-C. Zhao, Z.-H. Tang, L.-X. Li, W.-P. Jia. Prevalence and clinical characteristics of non-alcoholic fatty liver disease in newly diagnosed patients with ketosis-onset diabetes. Diabetes & Metabolism 2018; 44(5): 437 doi: 10.1016/j.diabet.2018.03.002
|
| 51 |
Alessandro Mantovani, Andrea Dalbeni, Giorgia Beatrice, Davide Cappelli, Fernando Gomez-Peralta. Non-Alcoholic Fatty Liver Disease and Risk of Macro- and Microvascular Complications in Patients with Type 2 Diabetes. Journal of Clinical Medicine 2022; 11(4): 968 doi: 10.3390/jcm11040968
|
| 52 |
Mohsen Afarideh, Zahra Aryan, Alireza Ghajar, Morsaleh Ganji, Fatemeh Ghaemi, Mohammad Saadat, Behnam Heidari, Jeffrey I. Mechanick, Alireza Esteghamati. Association of non-alcoholic fatty liver disease with microvascular complications of type 2 diabetes. Primary Care Diabetes 2019; 13(6): 505 doi: 10.1016/j.pcd.2019.03.009
|
| 53 |
Ali Bayat Bodaghi, Erfan Ebadi, Mohammad Javad Gholami, Reza Azizi, Aref Shariati. A decreased level of high‐density lipoprotein is a possible risk factor for type 2 diabetes mellitus: A review. Health Science Reports 2023; 6(12) doi: 10.1002/hsr2.1779
|
| 54 |
Andriy Ya. Sabovchyk. EFFECT OF NON-ALCOHOLIC FATTY LIVER DISEASE ON THE COURSE OF DIABETIC POLYNEUROPATHY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. Wiadomości Lekarskie 2023; 76(11): 2395 doi: 10.36740/WLek202311109
|
| 55 |
Isabel M.A. Brüggenwirth, Natasha H. Dolgin, Robert J. Porte, Adel Bozorgzadeh, Paulo N.A. Martins. Donor Diabetes and Prolonged Cold Ischemia Time Synergistically Increase the Risk of Graft Failure After Liver Transplantation. Transplantation Direct 2017; 3(7): e173 doi: 10.1097/TXD.0000000000000692
|
| 56 |
Meng Zhang, Li Li, Jing Chen, Bei Li, Yutao Zhan, Chuan Zhang. Presence of diabetic retinopathy is lower in type 2 diabetic patients with non-alcoholic fatty liver disease. Medicine 2019; 98(18): e15362 doi: 10.1097/MD.0000000000015362
|
| 57 |
Yuqing Zhao, Lijun Xie, Ning Ou, Jie Wu, Hongwen Zhang, Sufeng Zhou, Yun Liu, Juan Chen, Lu Wang, Libin Wang, Jingjing Wang, Feng Shao. Tolerability, safety, pharmacokinetics and pharmacodynamics of SHR0534, a potent G protein-coupled receptor 40 (GPR40) agonist, at single- and multiple-ascending oral doses in healthy Chinese subjects. Xenobiotica 2021; 51(3): 297 doi: 10.1080/00498254.2020.1864510
|
| 58 |
Xin Wen, Xianghai Zhou, Da Chen, Jiayu Cheng, Linong Ji. Association Between Non-Alcoholic Fatty Liver Disease and Diabetes-Related Microvascular Complications: A Retrospective Cross-Sectional Study of Hospitalized Patients. Endocrine Practice 2022; 28(3): 304 doi: 10.1016/j.eprac.2021.02.004
|
| 59 |
Aakriti Soni, Anuroop Yekula, Yuvaraj Singh, Nitish Sood, Dushyant Singh Dahiya, Kannu Bansal, GM Abraham. Influence of non-alcoholic fatty liver disease on non-variceal upper gastrointestinal bleeding: A nationwide analysis. World Journal of Hepatology 2023; 15(1): 79-88 doi: 10.4254/wjh.v15.i1.79
|
| 60 |
Dandan Song, Chengqian Li, Zhongchao Wang, Yuhang Zhao, Baoming Shen, Wenjuan Zhao. Association of non‐alcoholic fatty liver disease with diabetic retinopathy in type 2 diabetic patients: A meta‐analysis of observational studies. Journal of Diabetes Investigation 2021; 12(8): 1471 doi: 10.1111/jdi.13489
|
| 61 |
Carla Greco, Fabio Nascimbeni, Francesca Carubbi, Pietro Andreone, Manuela Simoni, Daniele Santi. Association of Nonalcoholic Fatty Liver Disease (NAFLD) with Peripheral Diabetic Polyneuropathy: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine 2021; 10(19): 4466 doi: 10.3390/jcm10194466
|
| 62 |
Marcin Kosmalski, Sylwia Ziółkowska, Piotr Czarny, Janusz Szemraj, Tadeusz Pietras. The Coexistence of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus. Journal of Clinical Medicine 2022; 11(5): 1375 doi: 10.3390/jcm11051375
|
| 63 |
Cui-Chun Zhao, Ai-Ping Wang, Lian-Xi Li, Ting-Ting Li, Ming-Yun Chen, Yue Zhu, Tian-Pei Yu, Yu-Qian Bao, Wei-Ping Jia. Urine uric acid excretion is associated with nonalcoholic fatty liver disease in patients with type 2 diabetes. Journal of Diabetes and its Complications 2016; 30(6): 1074 doi: 10.1016/j.jdiacomp.2016.04.017
|
| 64 |
Xi Gu, Dou Tang, Yan Xuan, Ying Shen, Lei Qun Lu. Association between nonalcoholic fatty liver disease and peripheral neuropathy in US population, a cross-sectional study. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-32115-4
|